[Table/Fig-3]:
Baseline characteristics of the study participants.
| Placebo n=8 |
Curcumin n=12 |
|
|---|---|---|
| Age (mean±S.D.) | 52.75± 9.43 | 49.42± 11.22 |
| Male | 5 (62.5%) | 2 (16.7%) |
| Female | 3 (37.3%) | 10 (83.3%) |
| History of previous treatment | 5 (62.5%) | 4 (33.3%) |
| Skin involvement | 1 (12.5%) | 2 (16.7%) |
| Site of OLP | ||
| Bucal | 8 (62%) | 10 (47%) |
| Tongue | 4 (31%) | 6 (25%) |
| Gingiva | 0 | 5 (23%) |
| Lip | 1 (7%) | 1 (5%) |
| Systemic disease | 4 (50%) | 7(58.3%) |
| Pain and sensation score (mean±S.D.) | 4.63±3.20 | 6.5±2.15 |
| Thangprasom score | 3±1.30 | 3.17±1.03 |